Who can use LIBTAYO(Lebrikizumab)?

LIBTAYO (lebrikizumab) is indicated for adults with moderate-to-severe atopic dermatitis who are candidates for systemic therapy. Eligibility requires inadequate response to or intolerance of other treatments.

Who can use LIBTAYO(Lebrikizumab)?

Patients must have a confirmed diagnosis of atopic dermatitis, with disease severity warranting systemic intervention. Contraindications include hypersensitivity to lebrikizumab or its components. Healthcare providers assess individual suitability, considering medical history, concurrent medications, and potential risks (e.g., infections). Pregnant or breastfeeding individuals should consult their doctor due to limited safety data in these groups. Always follow a physician’s guidance for proper use.